Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted pyrrolo[2,3-d]pyrimidines for the treatment of cancer and proliferative disorders

Substituted pyrrolo[2,3-d]pyrimidines for the treatment of cancer and proliferative disorders

US Patent 9981968 · Granted May 29, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted 3-amino-5-phenylbenzamide compounds as covalent inhibitors of enhanc2025
Substituted [1,2,4]triazolo[4,3-c]pyrimidines that induce degradation of embryon2025
Agents that target telomerase reverse transcriptase (TERT) for treating cancer a2025
3-methylideneoxan-4-one compounds and substituted derivates thereof as inhibitor2025
Bifunctional compounds comprising Apcin-A and their use in the treatment of canc2025
Substituted chromanes, analogs thereof, and methods of use and synthesis2025
Oligonucleotide-based proteolysis targeting chimera2025
Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of in2025
Substituted fused pyrrolo-diazepinones and uses thereof2025
Substituted fused pyrrolo-diazepinones and uses thereof2025
Substituted heterocycles as c-MYC targeting agents2024
Substituted 3-amino-5-phenylbenzamide compounds as covalent inhibitors of enhanc2024